State of New Jersey Common Pension Fund D Boosts Position in Hims & Hers Health, Inc. $HIMS

State of New Jersey Common Pension Fund D raised its stake in Hims & Hers Health, Inc. (NYSE:HIMS) by 0.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,163 shares of the company’s stock after purchasing an additional 507 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Hims & Hers Health were worth $3,099,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. AlphaQuest LLC grew its position in shares of Hims & Hers Health by 110.2% in the 2nd quarter. AlphaQuest LLC now owns 7,288 shares of the company’s stock valued at $363,000 after buying an additional 3,821 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in Hims & Hers Health in the second quarter valued at $1,440,000. First Citizens Bank & Trust Co. purchased a new position in shares of Hims & Hers Health during the second quarter worth about $571,000. Bleakley Financial Group LLC acquired a new stake in shares of Hims & Hers Health during the second quarter worth about $1,918,000. Finally, Freedom Investment Management Inc. increased its position in shares of Hims & Hers Health by 58.4% during the second quarter. Freedom Investment Management Inc. now owns 20,384 shares of the company’s stock worth $1,016,000 after purchasing an additional 7,514 shares in the last quarter. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Insider Transactions at Hims & Hers Health

In other Hims & Hers Health news, insider Michael Chi sold 900 shares of the company’s stock in a transaction on Friday, October 10th. The stock was sold at an average price of $58.25, for a total value of $52,425.00. Following the sale, the insider owned 291,439 shares of the company’s stock, valued at approximately $16,976,321.75. This represents a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Soleil Boughton sold 2,637 shares of Hims & Hers Health stock in a transaction on Monday, October 13th. The stock was sold at an average price of $54.38, for a total value of $143,400.06. Following the transaction, the insider directly owned 161,130 shares of the company’s stock, valued at $8,762,249.40. This trade represents a 1.61% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,429,634 shares of company stock valued at $74,097,471 in the last three months. 17.71% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HIMS. KeyCorp began coverage on Hims & Hers Health in a research note on Tuesday, October 21st. They set a “sector weight” rating on the stock. Wall Street Zen lowered shares of Hims & Hers Health from a “buy” rating to a “hold” rating in a research report on Monday, July 28th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Hims & Hers Health in a report on Tuesday, October 14th. Truist Financial decreased their price target on shares of Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating for the company in a research note on Monday, August 18th. Finally, Zacks Research downgraded shares of Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 19th. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Hims & Hers Health presently has an average rating of “Reduce” and an average price target of $38.92.

Hims & Hers Health Stock Down 0.8%

HIMS stock opened at $48.40 on Tuesday. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. The company’s 50-day moving average price is $51.20 and its 200 day moving average price is $49.94. Hims & Hers Health, Inc. has a 52 week low of $18.33 and a 52 week high of $72.98. The company has a market cap of $10.94 billion, a P/E ratio of 60.50, a P/E/G ratio of 3.38 and a beta of 2.25.

Hims & Hers Health (NYSE:HIMS) last issued its earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The company had revenue of $544.83 million during the quarter, compared to analysts’ expectations of $550.06 million. Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. The company’s quarterly revenue was up 72.6% on a year-over-year basis. During the same period last year, the business posted $0.06 earnings per share. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.